Medtronic gains FDA approval for personalized pacemaker

08/26/2014 | (Boston)

The FDA has granted Medtronic approval to market its Viva CRT-P system for use in treating patients with heart failure or atrioventricular block. The cardiac resynchronization therapy-pacemaker alters its pacing parameters according to a patient's cardiac rhythms using proprietary software.

View Full Article in: (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX